Legato Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,823
| Closed | -$409K | – | 604 |
|
|
2025
Q1 | $409K | Buy |
10,823
+1,818
| +20% | +$68.6K | 0.06% | 452 |
|
|
2024
Q4 | $737K | Sell |
9,005
-2,627
| -23% | -$215K | 0.1% | 371 |
|
|
2024
Q3 | $1.33M | Buy |
11,632
+613
| +6% | +$70K | 0.16% | 218 |
|
|
2024
Q2 | $832K | Buy |
11,019
+3,010
| +38% | +$227K | 0.11% | 307 |
|
|
2024
Q1 | $547K | Sell |
8,009
-4,187
| -34% | -$286K | 0.07% | 422 |
|
|
2023
Q4 | $766K | Buy |
12,196
+1,498
| +14% | +$94.1K | 0.1% | 324 |
|
|
2023
Q3 | $545K | Sell |
10,698
-9,210
| -46% | -$470K | 0.08% | 381 |
|
|
2023
Q2 | $994K | Buy |
19,908
+13,383
| +205% | +$668K | 0.13% | 262 |
|
|
2023
Q1 | $245K | Buy |
6,525
+2,334
| +56% | +$87.5K | 0.04% | 429 |
|
|
2022
Q4 | $201K | Buy |
+4,191
| New | +$201K | 0.04% | 453 |
|